Getting De-Centralized Testing into Routine Clinical Oncology Using High-Performance Genetic Multiplexing Using Digital PCR

Time: 10:15 am
day: Day Two


  • Bring uncompromised real-time oncology monitoring and management to patients
  • High assay standardization and performance democratize this liquid biopsy tool for the absolute quantification of ctDNA, enabling longitudinal disease molecular assessment and treatment management
  • Fixed or customized panels as companion diagnostics for seamless deployment directly into medical centers